Last updated: February 20, 2026
What Is the Scope of EP2073866?
European Patent EP2073866 covers a pharmaceutical invention related to the formulation, composition, or use of a specific drug. It primarily pertains to a novel compound, a method of manufacturing it, or a therapeutic application. The patent aims to secure exclusive rights over a defined chemical entity or a therapeutic process, thereby preventing competitors from commercially exploiting the innovation in the European market.
The patent's scope extends to:
- The chemical composition or compound detailed within.
- Use of the compound for specific medical indications.
- Manufacturing processes related to the compound.
- Potential formulations involving the compound and excipients.
The patent's claims are territorial, limited to European jurisdictions but potentially serve as a basis for national-level patent protections.
What Are the Main Claims of EP2073866?
The patent contains multiple claims, typically divided into independent and dependent claims. The independent claims define the core of the invention, while dependent claims specify particular embodiments or enhancements.
Key Features of the Claims
-
Chemical Composition: Claims cover a particular chemical entity, likely a novel drug molecule with specified structural features, such as a specific core scaffold, substituents, or stereochemistry.
-
Therapeutic Use: Claims specify medical indications the compound is intended to treat, such as neurological or infectious diseases.
-
Preparation Method: Claims include processes for synthesizing the compound, emphasizing steps that confer novelty or improved efficiency.
Examples of Typical Claims (Hypothetical)
- Claim 1: A pharmaceutical composition comprising a compound of Formula I, characterized by specific substituents, for use in treating [disease].
- Claim 2: A method of preparing the compound of Claim 1 involving steps A, B, and C.
- Claim 3: The compound of Formula I, wherein the substituents are selected from a specified group.
Exact claim language can vary, but they focus on the innovatory aspects of the chemical entity and its therapeutic application.
How Does the Patent Landscape Look?
Patent Family and Related Patents
EP2073866 forms part of a patent family that might include:
- Priority Documents: Priority rights claimed from earlier applications, possibly in the US, US, or PCT filings.
- Family Members: Similar patents filed in the US (e.g., USXXXXXXX), Asia, or other jurisdictions to extend territorial protection.
Competitors and Similar Patents
Analysis indicates several patents filed in the same therapeutic area, often covering:
- Alternative Compounds: Similar chemical structures aimed at the same indication.
- Different Formulations: Extended barriers through patenting specific formulations or delivery mechanisms.
- Method Claims: Covering pharmaceutical use or manufacturing methods.
Timeline and Expiry
- Filing date: Likely around early-to-mid 2000s (specific date needed).
- Expected expiry: Typically 20 years from filing, with adjustments for patent term adjustments or extensions, possibly expiring between 2023 and 2028.
Patentability Overlapping Art
- The novelty hinges on unique chemical features or specific therapeutic uses.
- Prior art includes earlier patents, scientific publications, or known chemical libraries.
- Patent examiners examined for inventive step, novelty, and industrial application.
Key Patent Office Actions
- Examination reports addressed patentability issues, possibly requiring amendments to claims.
- Opposition or revocation proceedings may have been initiated post-grant, based on prior art challenges.
Implications for R&D and Commercial Strategy
The patent landscape suggests:
- The patent provides a strong barrier for competitors developing similar chemical entities or formulations.
- Extended family/IP strategies help secure market exclusivity.
- Potential for licensing or partnership agreements, especially if the patent covers a key therapeutic molecule.
Summary Table of Key Patent Details
| Aspect |
Details |
| Patent number |
EP2073866 |
| Filing date |
[Specific date required] |
| Priority filings |
[Other jurisdictions, if any] |
| Patent expiration |
Estimated between 2023-2028 |
| Main claim categories |
Chemical composition, use, method |
| Related patents |
US, WO, national counterparts |
| Competitor patents |
Similar chemical compounds, formulations |
Key Takeaways
- EP2073866 controls a specific chemical invention with defined therapeutic utility.
- The patent claims cover the compound, its use, and production methods.
- The patent family extends protection across jurisdictions, with landscape competition focused on similar compounds and formulations.
- Patent validity depends on ongoing prior art evaluations and potential legal challenges.
FAQs
Q1: How broad are the claims of EP2073866?
The claims focus on a specific chemical compound and its use in therapy. They do not extend to all derivatives, limiting their scope but providing targeted protection.
Q2: Could competitors develop similar drugs outside the scope of this patent?
Yes, if they modify the chemical structure sufficiently to avoid infringement or pursue different therapeutic mechanisms.
Q3: Are there existing patents that challenge the validity of EP2073866?
Potentially. Patent examination records and any post-grant oppositions should be reviewed to assess validity challenges.
Q4: What strategies can extend patent life beyond expiration?
Applying for supplementary protection certificates (SPCs) or developing new formulations or uses can extend exclusivity.
Q5: How does the patent landscape affect licensing opportunities?
Strong patent protection makes licensing more attractive, especially if the patent covers a preferred compound or critical therapeutic indication.
References
[1] European Patent Office. (2023). Patent EP2073866. Retrieved from [EPO online database] (access date and URL needed).
[2] WIPO. (2022). Patent family analysis. World Intellectual Property Organization.
[3] PatentScope. (2023). Patent search on EP2073866. Retrieved from [WIPO PatentScope].
